Details of the Drug
General Information of Drug (ID: DM1XY5F)
Drug Name |
MN-462
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms | EF-6265; CPB/TAFIa inhibitor, MediciNova; CPB/TAFIa inhibitor, Meiji Seika Kaisha/MediciNova; Carboxypeptidase B/thrombin-activated fibrinolysis inhibitor, Meiji Seika Kaisha/MediciNova | ||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Structure | 3D Structure is Not Available | ||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||